Incepto operates as an AI platform aggregator and integrator rather than a pure developer, curating best-in-class AI applications and distributing them via a single gateway with security, invoicing, and performance monitoring. The company differentiates through clinician co-creation, change management consulting, and a proprietary reporting automation tool (Tango), positioning it as an enabler of AI adoption rather than a point-solution vendor.
Cyborg Score Rationale
Incepto has secured $33.3M in funding, achieved deployment across 350+ centers, and earned recognition as a leader in the X-ray diagnostics AI market by CB Insights. The platform model with partner integrations and expanding European footprint demonstrate traction, though private status limits revenue visibility and competitive intensity in medical imaging AI remains high.
Top Insights
Platform mediator strategy reduces customer lock-in risk and enables rapid expansion of AI application catalog by integrating third-party developers
Proprietary Tango reporting tool (saving up to 45% radiologist time) creates sticky value-add beyond platform orchestration
AIRS Medical partnership (February 2025) and ScreenPoint distribution agreement signal traction with leading AI developers seeking distribution channels
Presence across 10+ European countries plus US expansion positions Incepto for regulated market scaling as medical imaging AI deployment accelerates post-2025
Named Competitors
Aidoc — Diagnostic imaging AI for radiologist workflow and AI-assisted detection
Viz.ai — Stroke and critical care imaging AI solutions for emergency departments
Gleamer — AI-powered chest X-ray and musculoskeletal imaging analysis
Lunit — AI-powered medical imaging platform for cancer detection and precision oncology
Viseur AI — AI solutions for healthcare medical image diagnostics and radiology workflow
Recent Developments
(February 2025) Announced partnership with AIRS Medical to distribute SwiftMR® for MRI solutions across European diagnostic imaging centers
(2024) Selected by France 2030 program (operated by La French Tech and French government) as key healthcare innovation player
(September 2022) Completed Series B funding round with participation from LBO France and other investors
Open the full interactive Incepto Medical report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.